Publications by authors named "M N Castel"

Article Synopsis
  • The study examines the use of anesthesia for non-cardiac procedures (NCPs) in patients with left ventricular assist devices (LVADs) between 2014 and 2023.
  • Out of 16 LVAD patients, 9 underwent a total of 22 NCPs, primarily in the endoscopy unit, with sedation used in most cases and no intraoperative complications reported.
  • Postoperative complications occurred in 36.4% of procedures, mainly involving lower gastrointestinal bleeding, but overall, standard anesthesia practices were effective for LVAD patients during NCPs.
View Article and Find Full Text PDF
Article Synopsis
  • Left bundle branch pacing (LBBP) is a potential alternative to cardiac resynchronization therapy (CRT) but is not suitable for all heart failure patients.
  • A study analyzed 187 CRT candidates, finding a success rate of 81.2% for LBBP implantation, with failed cases primarily due to poor QRS morphology and technical issues.
  • Key predictors for unsuccessful implantation included left ventricular end-diastolic diameter (LVEDD) and non-left bundle branch block (non-LBBB) morphology, with non-LBBB significantly increasing the risk of failure.
View Article and Find Full Text PDF

Aims: Longitudinal dyssynchrony correction and 'strain' improvement by comparable cardiac resynchronization therapy (CRT) techniques is unreported. Our purpose was to compare echocardiographic dyssynchrony correction and 'strain' improvement by conduction system pacing (CSP) vs. biventricular pacing (BiVP) as a marker of contractility improvement during 1-year follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the effectiveness and safety of the drug omalizumab for treating bullous pemphigoid (BP) in patients who did not respond to standard treatments, analyzing data from 100 patients across 18 medical centers in France from 2014 to 2021.
  • 77% of patients achieved complete remission (CR), and 9% achieved partial remission, with a median time to CR of approximately 3 months, although 14% experienced relapses within a median follow-up of 12 months.
  • Higher baseline levels of anti-BP180-NC16A IgE were linked to better CR outcomes, while other factors like urticarial lesions or eosinophil
View Article and Find Full Text PDF